PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth
SHANGHAI , Aug. 4, 2026 /PRNewswire/ -- AsymBio , a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), ...
2026-08-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
BOSTON and ROLLE, Switzerland , Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS  (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics ...
2026-08-04T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
MGI Tech and NCSTAR Sign Memorandum of Understanding to Explore Bringing Multi-Omics Infrastructure under DCSP framework to Queensland's Spatial Biology Research
Collaboration, coordinated through NCSTAR at QIMR Berghofer, gives Queensland researchers a pathway to trial and validate MGI's integrated DCSP framework — spanning DNA genomics, cell omics, spatial omics ...
2026-08-04T    Biotechnology 
Sisram Medical Powers Up China EBD Growth Engine with Flagship "黑金牛奶光" Launch
Driving Innovation and Proactive Empowerment to Unlock Localized Growth in China ...
2026-08-04T    Biotechnology   Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics 
Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
Piramal Pharma Solutions has added a new spray drying suite with Band 5 containment capacity at its dedicated peptide facility in Turbhe, India, equipped with its own air handling units, nitrogen supply, ...
2026-08-04T    Biotechnology   Chemical   Health Care/Hospital   Medical/Pharmaceuticals 
Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa
SHANGHAI , Aug. 4, 2026 /PRNewswire/ -- Innogen Pharmaceuticals ( HK.2591 ), a biopharmaceutical company dedicated to innovative drug discovery and industrialization in metabolic diseases, today announced ...
2026-08-04T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Ainex's ENAD Chosen for Singapore's National University Hospital After Global Competition
ENAD, Korea's First and Only AI-Assisted Solution Approved for Both Upper and Lower GI Endoscopy ENAD Secures Singapore Hospital Adoption in Competition with Medtronic, Olympus, and Fujifilm ...
2026-08-04T    Biotechnology   Education   Health Care/Hospital   Higher Education 
Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy
At the Precision Oncology Academy 2026, leading international experts explored how insights from tumour DNA and RNA can reveal treatment opportunities, explain drug resistance, and translate into more ...
2026-08-04T    Biotechnology   Medical Equipment   Medical/Pharmaceuticals 
Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
PUNE, India , Aug. 4, 2026 /PRNewswire/ -- Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), today announced the launch of NeX™, a transformative end-to-end ...
2026-08-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
KPJ Healthcare Launches First Orthopaedic and Rheumatology Centre of Excellence Under the KPJ Health System
BUKIT MERTAJAM, Malaysia , Aug. 4, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Orthopaedic and Rheumatology Centre of Excellence ...
2026-08-04T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.